Multifocal Motor Neuropathy  >>  Kenketsu Glovenin-I (normal human immunoglobulin IV)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kenketsu Glovenin-I (normal human immunoglobulin IV) / Takeda
NCT01827072: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.

Completed
3
13
Japan
NPB-01, immunoglobulin
Nihon Pharmaceutical Co., Ltd
Multifocal Motor Neuropathy
06/15
06/15

Download Options